# PET and MRI Imaging With Scopolamine at the Muscarinic M1 Receptor

> **NCT06014385** · PHASE1 · WITHDRAWN · sponsor: **Yale University**

## Conditions studied

- Muscarinic Receptor Occupancy

## Interventions

- **DRUG:** Scopolamine
- **RADIATION:** [11C]EMO ([11C]LSN3172176)

## Key facts

- **NCT ID:** NCT06014385
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-03
- **Primary completion:** 2025-07-01
- **Final completion:** 2025-07-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** lack of enrollment
- **Last updated:** 2025-05-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06014385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06014385, "PET and MRI Imaging With Scopolamine at the Muscarinic M1 Receptor". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06014385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*